A blue light activated anti-cancer prodrug, NST, was designed based on a photoactive 4-aminonaphthalimide derivative and an anticancer drug, 10-hydroxycamptothecin. NST was hard to be taken up by living cells and showed negligible dark cytotoxicity. The irradiation caused photocleavage of NST and resulted in high cytotoxicity.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/d1cc01847g | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!